These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13678696)

  • 21. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
    Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
    Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
    Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII.
    Hu Y; Repa A; Lisman T; Yerlikaya-Schatten G; Hau C; Pabinger I; Ay C; Nieuwland R; Thaler J
    J Thromb Haemost; 2022 Oct; 20(10):2306-2312. PubMed ID: 35748324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of the initiation of coagulation.
    Ott I
    Br J Clin Pharmacol; 2011 Oct; 72(4):547-52. PubMed ID: 21392058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
    Wilcox JN; Noguchi S; Casanova J
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):136-41. PubMed ID: 12524237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
    Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
    Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.
    O'Brien DP; Anderson JS; Martin DM; Byfield PG; Tuddenham EG
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):7-12. PubMed ID: 8503864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
    Sandset PM; Sirnes PA; Abildgaard U
    Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
    Chu AJ
    Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor mediates inflammation.
    Chu AJ
    Arch Biochem Biophys; 2005 Aug; 440(2):123-32. PubMed ID: 16036212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical strategies to anticoagulation: a comparative overview.
    Chu AJ
    Curr Vasc Pharmacol; 2004 Jul; 2(3):199-228. PubMed ID: 15320820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of porcine factor VII, X and comparison with human factor VII, X.
    Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
    Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.